CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 1 filers reported holding CUREVAC N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,287 | -67.8% | 774 | -50.9% | 0.00% | -50.0% |
| Q2 2023 | $16,412 | +205.8% | 1,575 | +104.5% | 0.00% | +100.0% |
| Q1 2023 | $5,367 | +116.1% | 770 | +86.9% | 0.00% | – |
| Q4 2022 | $2,484 | -77.4% | 412 | -70.4% | 0.00% | -100.0% |
| Q3 2022 | $11,000 | -78.4% | 1,390 | -63.1% | 0.00% | -85.7% |
| Q2 2022 | $51,000 | -10.5% | 3,769 | +28.6% | 0.01% | 0.0% |
| Q1 2022 | $57,000 | +21.3% | 2,931 | +115.8% | 0.01% | +16.7% |
| Q4 2021 | $47,000 | – | 1,358 | +14988.9% | 0.01% | – |
| Q3 2021 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |